204 related articles for article (PubMed ID: 29663676)
1. A single-center, pilot study evaluating a novel TriHex peptide- and botanical-containing eye treatment compared to baseline.
Reivitis A; Karimi K; Griffiths C; Banayan A
J Cosmet Dermatol; 2018 Jun; 17(3):467-470. PubMed ID: 29663676
[TBL] [Abstract][Full Text] [Related]
2. A Multi-Center Evaluation of Restorative Eye Treatment and INhance With Trihex Technology to Improve Aesthetic Outcomes When Used Pre- and Post-Blepharoplasty.
Lee WW; Fagien S; Murdock J; Bell M; Widgerow AD
Aesthet Surg J Open Forum; 2023; 5():ojac089. PubMed ID: 36727033
[TBL] [Abstract][Full Text] [Related]
3. Reduced appearance of under-eye bags with twice-daily application of epidermal growth factor (EGF) serum: a pilot study.
Seidel R; Moy RL
J Drugs Dermatol; 2015 Apr; 14(4):405-10. PubMed ID: 25844616
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
[TBL] [Abstract][Full Text] [Related]
5. Anti-aging proof of concept study: results and summary.
Bruce S; Karnik J; Dryer L; Burkholder D
J Drugs Dermatol; 2014 Sep; 13(9):1074-81. PubMed ID: 25226008
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
Ascher B; Rzany BJ; Grover R
Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
8. An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin.
Draelos ZD; Kononov T; Fox T
J Drugs Dermatol; 2016 Sep; 15(9):1100-6. PubMed ID: 27602972
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid microneedle patch for the improvement of crow's feet wrinkles.
Choi SY; Kwon HJ; Ahn GR; Ko EJ; Yoo KH; Kim BJ; Lee C; Kim D
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28892233
[TBL] [Abstract][Full Text] [Related]
10. Novel bioactive formulation derived from the conditioned medium of mesenchymal stromal cells reduces under-eye dark circles in human volunteers.
Bhat S; Amirthalingam M; Ballambat SP; Bhupasandra Vasudev M; Gupta PK; Padya BS; Mutalik S; Seetharam RN
J Cosmet Dermatol; 2022 Feb; 21(2):814-826. PubMed ID: 33835668
[TBL] [Abstract][Full Text] [Related]
11. A novel, volumizing cosmetic formulation significantly improves the appearance of target Glabellar lines, nasolabial folds, and crow's feet in a double-blind, vehicle-controlled clinical trial.
Farris PK; Edison BL; Weinkauf RL; Green BA
J Drugs Dermatol; 2014 Jan; 13(1):41-6. PubMed ID: 24385118
[TBL] [Abstract][Full Text] [Related]
12. The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet Botulinum toxin type A chemodenervation.
Carruthers J; Carruthers A
Dermatol Surg; 2004 Mar; 30(3):355-66; discussion 366. PubMed ID: 15008861
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Split-Face/Décolleté Comparative Trial of Procedure Enhancement System for Fractional non-Ablative Laser Resurfacing Treatment.
Robinson DM; Frulla AP
J Drugs Dermatol; 2017 Jul; 16(7):707-710. PubMed ID: 28697226
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel anti-aging topical formulation containing cycloastragenol, growth factors, peptides, and antioxidants.
Weiss RA; Weiss MA
J Drugs Dermatol; 2014 Sep; 13(9):1135-9. PubMed ID: 25226016
[TBL] [Abstract][Full Text] [Related]
15. Use of topical ascorbic acid and its effects on photodamaged skin topography.
Traikovich SS
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1091-8. PubMed ID: 10522500
[TBL] [Abstract][Full Text] [Related]
16. Effect of a preparation containing a fucose-rich polysaccharide on periorbital wrinkles of human voluntaries.
Robert C; Robert AM; Robert L
Skin Res Technol; 2005 Feb; 11(1):47-52. PubMed ID: 15691259
[TBL] [Abstract][Full Text] [Related]
17. Global periorbital skin rejuvenation by a topical eye cream containing low molecular weight heparan sulfate (LMW-HS) and a blend of naturally derived extracts.
Colvan L; Fleck T; Vega VL
J Cosmet Dermatol; 2019 Apr; 18(2):530-538. PubMed ID: 30636356
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of a novel skin cream for improving periocular rhytids and dryness.
Calkin JM; Boudreaux AA; Taylor B
J Cosmet Dermatol; 2022 Nov; 21(11):5769-5778. PubMed ID: 35851986
[TBL] [Abstract][Full Text] [Related]
19. Clinical Evidence of Dermal and Epidermal Restructuring from a Biologically Active Growth Factor Serum for Skin Rejuvenation.
Barone F; Bashey S; Woodin Jr. FW
J Drugs Dermatol; 2019 Mar; 18(3):290-295. PubMed ID: 30909351
[TBL] [Abstract][Full Text] [Related]
20. Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials.
Baumann L; Dayan S; Connolly S; Silverberg N; Lei X; Drinkwater A; Gallagher CJ
Dermatol Surg; 2016 May; 42(5):598-607. PubMed ID: 27110893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
